Late Phase Studies

Our expertise in Late Phase Studies helps demonstrate product efficacy, safety and acceptance. Analyses and publications generated from the validated data obtained from these studies provide critical insight to the real-world use of a product or demonstrate evolving best practice patterns.

BioQuest creates value in generation of clinical effectiveness data, supports & strengthens product safety profile, provides ‘real world’ clinical and economic outcomes, impacts quality of patient care, integrates clinical safety, optimizes marketing and commercialization aspects of a product, provides insight into new market opportunities, identifies new subject populations & indications, provides competitive positioning, and generates and publishes clinical data on a product to drive market leadership

Our Services

• Non-interventional, Observational Research
• Disease and Product Registries
• Post-Approval Safety-Surveillance Studies
• Phase IV Clinical Trials
• Consumer Healthcare/OTC Trials
• Epidemiologic Studies
• Patient-Reported Outcomes/Quality-of-Life Research
• Health Economic Evaluations
• Naturalistic/Experience Data
• Off Label Indications
• Investigator Initiated Late Phase Trials
• Retrospective Data Analysis
• Cost Effective/Compliance Studies/Pharmacoeconomics
• Product Surveys
• Comparative Effectiveness & Outcomes Research
• Site Management (Site Set Ups, Initiation, IRB Submissions, Recruitment, Documentation, AE Management)
• Project Management (Protocol Implementation, Timelines, Recruitment Strategies, Placement of Trained Medical Coordinators, Site-Sponsor/CRO Communications)
• Monitoring Through an External Agency
• Detailed Feasibility Reports